Deep Learning can Predict Lung Cancer Risk from Single LDCT Scan

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference.

The model, called Sybil, which was originally developed using National Lung Screening Trial (NLST) data by investigators from the Massachusetts Institute of Technology and Harvard Medical School, could be used to guide more personalized lung cancer screening strategies. It could be an especially valuable tool in Asia, where incidence of lung cancer in nonsmokers is rising, and many people without conventional risk factors don’t meet screening guidelines, researchers said.

"Sybil demonstrated the potential to identify true low-risk individuals who may benefit from discontinuing further screening, as well as to detect at-risk groups who should be encouraged to continue screening," said corresponding author Yeon Wook Kim, MD, a pulmonologist and researcher at Seoul National University Bundang Hospital in Seongnam, Republic of Korea.

Current international guidelines do not recommend lung cancer screening for people considered lower-risk, such as individuals who have never smoked. However, lung cancer rates are rising in this group, and the lung cancer burden in this population is significant.

This disconnect between risk and screening is especially a concern in Asia. The region accounts for more than 60 percent of new lung cancer cases and related deaths globally, with a rising incidence among people who have never smoked, Dr. Kim said. He also noted that the epidemiology of lung cancer in Asia is different from the populations where screening criteria were developed and validated. This has led to an increase in screening that is self-initiated or not consistent with guidelines, but there's a lack of data to suggest who should be screened and who should not.

For the new paper, researchers evaluated more than 21,000 individuals aged 50-80 who underwent self-initiated LDCT screening between 2009 and 2021 and followed their outcomes until 2024. The screening tests were analyzed by Sybil to calculate the risk of future lung cancer diagnosis. The model demonstrated good performance in predicting cancer diagnosis at both one and six years, including in never-smokers.

"Sybil's value lies in its unique ability to predict future lung cancer risk from a single LDCT scan, independent of other demographic factors that are conventionally used for risk stratification," Dr. Kim said.

The model could be used to develop personalized strategies for individuals who have already undergone LDCT screening but have not received further recommendations for additional screening or follow-up. Prospective validation will be needed to confirm the model's potential for clinical use.

Researchers plan to follow up on the study.

"Based on our results, we are eager to conduct a prospective study to further validate and apply Sybil in a pragmatic clinical setting, as well as to enhance the model's ability to predict other important outcomes, such as lung cancer-specific mortality," Dr. Kim said.

YW Kim, J Oh, J Park, M Kim, DY Kim, JG Nam, D-H Joo, C-T Lee.
Validation of Sybil Deep Learning Lung Cancer Risk Prediction Model in Asian High- and Low-risk Individuals.
Am J Respir Crit Care Med 2025;211:A5012. doi: 10.1164/ajrccm.2025.211.Abstracts.A5012

Most Popular Now

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...